Nebenwirkungen · Besremi
Besremi 250 micrograms/0.5 mL solution for injection in pre-filled pen Besremi 500 micrograms/0.5 mL solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 8
HOS-135534 · Präparat HOS-097722
System organ class Frequency Adverse reaction Infections and common respiratory tract infection, influenza, rhinitis, fungal skin infestations infection uncommon oral herpes, herpes zoster, oral candidiasis, sinusitis, oesophageal candidiasis, vulvovaginal mycotic infection, hordeolum, onychomycosis Blood and lymphatic very common leukopenia, thrombocytopenia system disorders common pancytopenia, neutropenia, anaemia Immune system uncommon sarcoidosis disorders very rare idiopathic or thrombotic thrombocytopenic purpura# not known Vogt-Koyanagi-Harada disease#, acute hypersensitivity reactions#** Endocrine disorders common hypothyroidism, hyperthyroidism, thyroiditis uncommon Basedow's disease, diabetes mellitus# Metabolism and common hypertriglyceridaemia, decreased appetite nutrition disorders Psychiatric disorders common depression, aggression#, insomnia, anxiety, mood altered, mood swings, mood disorders uncommon suicide attempt#, suicidal ideation#, confusional state#, acute stress disorder, hallucination, emotional distress, nervousness nightmare, irritability rare bipolar disorder#, mania#
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-24T15:08:00Z · SHA-256 b821a9d463d0e9f05f3c2788ab2015a721e1b4a1ebc9433fe4d8072c0d2af2de · Passage 77fd9f9344f00a5c5a2dfd2bfda4cd433d6af0ef67a61864b03b0feca0d8b9c1 · Zeichen 1120–2895 im Abschnitt